Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
Oncology Today with Dr Neil Love
00:00
Molecular Progression and PADA1 Findings
Joyce reviews PADA-1: switching at ctDNA-detected ESR1 emergence to fulvestrant plus palbociclib improved PFS versus waiting.
Play episode from 41:28
Transcript
